Literature DB >> 10731415

Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis.

M Turunen1, J M Peters, F J Gonzalez, S Schedin, G Dallner.   

Abstract

The control of ubiquinone biosynthesis by peroxisome proliferators was investigated using peroxisome proliferator activated receptor alpha (PPARalpha)-null mice. Administration of 2-(diethylhexyl)phthalate to control mice resulted in elevated ubiquinone levels in the liver, while dolichol, dolichyl-P and cholesterol concentrations remained unchanged. In PPARalpha-null mice, the level of these lipids were similar to control levels and administration of the peroxisome proliferator did not increase the levels of ubiquinone. The increase in ubiquinone levels was the result of increased synthesis. Induction was most pronounced in liver, kidney and heart, which have relatively high levels of PPARalpha. When the tissue concentration of hydrogen peroxide was elevated by inhibition of catalase activity with aminotriazole, the amount of ubiquinone was not increased, suggesting that the induction of ubiquinone synthesis occured through a direct mechanism. The activities of branch-point enzymes FPP-synthase, squalene synthase, cis-prenyltransferase, trans-prenyltransferase and NPHB-transferase were substantially increased in control but not in PPARalpha-null mice after treatment with peroxisome proliferators. These data suggest that the induction of ubiquinone biosynthesis after administration of peroxisome proliferators is dependent on the PPARalpha through regulation of some of the mevalonate pathway enzymes. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731415     DOI: 10.1006/jmbi.2000.3596

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Role of oxidative stress in germ cell apoptosis induced by di(2-ethylhexyl)phthalate.

Authors:  Emiko Kasahara; Eisuke F Sato; Mami Miyoshi; Ryusei Konaka; Keiichi Hiramoto; Junzo Sasaki; Masaaki Tokuda; Yoshihisa Nakano; Masayasu Inoue
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  Hydroxylation of demethoxy-Q6 constitutes a control point in yeast coenzyme Q6 biosynthesis.

Authors:  S Padilla; U C Tran; M Jiménez-Hidalgo; J M López-Martín; A Martín-Montalvo; C F Clarke; P Navas; C Santos-Ocaña
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

Review 3.  Biochemical Assessment of Coenzyme Q10 Deficiency.

Authors:  Juan Carlos Rodríguez-Aguilera; Ana Belén Cortés; Daniel J M Fernández-Ayala; Plácido Navas
Journal:  J Clin Med       Date:  2017-03-05       Impact factor: 4.241

4.  Idebenone and coenzyme Q10 are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases.

Authors:  Jens Tiefenbach; Lilia Magomedova; Jiabao Liu; Arkadiy A Reunov; Ricky Tsai; Neena S Eappen; Rebecca A Jockusch; Corey Nislow; Carolyn L Cummins; Henry M Krause
Journal:  Dis Model Mech       Date:  2018-08-31       Impact factor: 5.758

5.  Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats.

Authors:  Kajal Rajdev; Ehraz Mehmood Siddiqui; Kuldeep Singh Jadaun; Sidharth Mehan
Journal:  IBRO Rep       Date:  2020-04-22

6.  Cell survival from chemotherapy depends on NF-kappaB transcriptional up-regulation of coenzyme Q biosynthesis.

Authors:  Gloria Brea-Calvo; Emilio Siendones; José A Sánchez-Alcázar; Rafael de Cabo; Plácido Navas
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

7.  Molecular Mechanisms Associated with the Induction of Ubiquinone by Peroxisome Proliferators.

Authors:  Seher Akhtar Khan
Journal:  Gastroenterology Res       Date:  2009-01-20

Review 8.  Coenzyme Q10 Supplementation in Aging and Disease.

Authors:  Juan D Hernández-Camacho; Michel Bernier; Guillermo López-Lluch; Plácido Navas
Journal:  Front Physiol       Date:  2018-02-05       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.